FastNeura

What FastNeura does

FastNeura Inc. is a private Japanese neurotechnology startup founded in February 2024 and headquartered in Bunkyo-ku, Tokyo, that originated from the University of Tokyo. The company is building "Sync," a cognitive augmentation OS that integrates neuroscience research with human-computer interaction (HCI) and AI technologies to read, write, and optimize human cognitive states. Its core capabilities include multimodal biosignal analysis (notably EEG), cognitive state estimation AI, and closed-loop intervention technology that pairs software with proprietary sensory-stimulation hardware.

The company monetizes across three service lines: collaborative joint R&D with enterprises and academia spanning neuroscience, biological data analysis, Agent AI, and Physical AI; proprietary product development combining non-verbal information integration infrastructure with sensory-stimulation hardware; and platform deployment of the Sync OS. Target verticals include healthcare and wellness, defense and security, living spaces, labor and workplace, and space. Distribution is enterprise-direct via custom R&D contracts and consortium participation, including Japan's Cabinet Office SIP Human Augmentation Consortium alongside Toyota, Sony, and NTT Docomo, and the RESCUE medical/bio consortium with JISDA Corporation. Pricing is not publicly disclosed.

The team consists of approximately 30 experts, all with research achievements in neuroscience and/or AI, many currently enrolled in or affiliated with graduate programs at top Japanese institutions. Leadership includes CEO/Founder 水口 成寛 (Nayuta Mizuguchi, University of Tokyo Faculty of Medicine), CTO 苅山 湊 (Minato Kariyama), COO Haruka, CSO 小久保 廉汰 (Renta Kokubo), CTO 中田 昂成 (Taisei Nakada), CNTO 水野 晋之介 (Shinnosuke Mizuno), and Executive Officer 平塚 蒼大 (Sodai Hiratsuka) overseeing business development and brand strategy. No funding rounds, revenue figures, paying customer logos, patents, or trademarks have been disclosed in the input data.

Name

FastNeura

Legal name

FastNeura Inc.

Website

https://fastneura.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

FastNeura is a Tokyo-based University of Tokyo-originated neurotech startup founded February 2024, building Sync—a cognitive augmentation OS using multimodal biosignal analysis and AI to read, write, and optimize human cognitive states across healthcare, defense, space, and workplace sectors.

Ownership category

akta.pro rank

Product category

Neurotechnology / Cognitive Augmentation Platform

NAICS

Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Cognitive augmentation platform
• Neuroscience AI startup
• Multimodal biosignal analysis
• Brain computer interface
• Closed-loop neurotechnology

Headquarters

HQ city

Hongo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Collaborative Research and Development: Joint R&D services with enterprises and academia across unexplored research domains from neuroscience to Agent and Physical AI technologies
2. Product Development: Development and provision of proprietary products including non-verbal information integration platforms and sensory stimulation hardware
3. Platform Services (Sync): OS-level cognitive augmentation services deployed across healthcare, defense, living spaces, labor, and space sectors

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Core offering

FastNeura develops and provides Sync, a next-generation cognitive augmentation operating system that integrates neuroscience research with HCI and AI technologies to read, write, and optimize human cognitive states. The offering is delivered via three lines: collaborative research and development with enterprises and academia, custom software and hardware product development (including non-verbal information integration platforms and sensory stimulation hardware), and deployment of the Sync platform across healthcare, defense, living spaces, labor, and space sectors.

Product overview

FastNeura offers a unified platform architecture centered on Sync, a cognitive augmentation OS that integrates neuroscience research with HCI and AI technologies. The product portfolio includes three service lines (joint research/development, product development, and platform deployment) that work together to provide an end-to-end solution: from collaborative R&D and custom product development (software and hardware) to the deployment of the Sync OS platform for cognitive state management. The company operates as a neurotech startup originating from the University of Tokyo, specializing in multimodal biosignal analysis, cognitive state estimation AI, and closed-loop intervention technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Sync Platform (認知拡張OS) Next-generation cognitive augmentation operating system that seamlessly integrates neuroscience research with HCI and AI technologies. Sync reads, writes, and optimizes human cognitive states and includes Ambient Agent and Hardware components for deployment across healthcare, defense, living spaces, labor, and space domains.
• Collaborative Research and Development (共同研究・開発)

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Six partnerships are on record, tiered flagship and core.

• Cabinet Office SIP Human Augmentation ConsortiumflagshipStrategic or Co-development Partner · 8 April 2026FastNeura participates as a member in Japan's Cabinet Office-led Human Augmentation Consortium as part of the SIP Phase 3 project. The consortium includes major corporations such as Toyota, Sony, and NTT Docomo. FastNeura aims to advance human augmentation technologies, especially in cognitive intervention, through this national-level collaborative initiative.
• JISDA CorporationcoreStrategic or Co-development Partner · 8 April 2026Strategic collaboration in cognitive support and biosensing within the medical and bio consortium 'RESCUE'. The partnership combines FastNeura's neurotechnology including multimodal biosignal analysis, cognitive state estimation AI, and closed-loop intervention technology with JISDA's defense and security implementation capabilities.
• TUNE ProjectcoreStrategic or Co-development Partner · 7 April 2026Memorandum of understanding (MOU) signed for collaboration on advancing neurofeedback technology. FastNeura provides biological adaptive AI analysis capabilities while TUNE contributes scientific meditation programs. The partnership aims to enhance and implement neurofeedback technology.
• Regeneosome Inc.coreStrategic or Co-development Partner · 25 March 2026Collaborative research project with Regeneosome Inc., a longevity tech venture and subsidiary of Space Seed Holdings Co., Ltd. The research scientifically evaluates the effects of hypoxic environments on cognitive function through EEG measurements, with applications for office wellness programs and personalized multi-domain intervention platforms.
• Space DatacoreStrategic or Co-development PartnerBusiness partnership for AGI society with Space Data, focusing on connecting 'environment' and 'humans' in real-time through next-generation infrastructure co-development.
• Applied Neuroscience Consortium (CAN)coreStrategic or Co-development PartnerActive participation in the Applied Neuroscience Consortium (CAN), delivering technical presentations on Sync cognitive intervention platform technology.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Alto Neuroscience: Alto Neuroscience uses AI and biomarker-driven approaches to characterize brain states for psychiatric drug development. Comparable in the AI-on-brain-data approach but focused on pharma rather than direct cognitive intervention.
• Cogstate: Cogstate provides computerized cognitive testing and assessment tools used in clinical trials and healthcare. Partially comparable to FastNeura's cognitive state estimation capabilities, focused on assessment rather than intervention.

Direct peers

• Dreem: Dreem develops EEG headbands and software for sleep and cognitive performance. Directly relevant to FastNeura's closed-loop intervention and neurofeedback offerings targeting cognitive optimization.
• Kernel: Kernel builds non-invasive neural interfaces and cognitive measurement hardware/software. It is a direct peer to FastNeura's Sync platform as both pursue biosignal-based cognitive state estimation and human augmentation applications.
• Neurable: Neurable builds EEG-based BCI software and integrates into consumer audio products for focus and productivity. Directly comparable as a software/AI layer on top of biosignal capture for cognitive state applications.
• BrainCo: BrainCo develops EEG-based wearables and brain-computer interface products spanning education, wellness, and prosthetics. Its combination of biosignal hardware and a software platform parallels FastNeura's Sync OS approach.
• Emotiv: Emotiv makes EEG headsets and a software platform for research, wellness, and BCI applications. Comparable in the multimodal biosignal analysis and cognitive monitoring stack that underpins Sync.
• Muse (Interaxon): Muse produces consumer EEG headbands and neurofeedback apps, with a platform approach to cognitive state and meditation. It is directly comparable to FastNeura's neurofeedback and cognitive intervention stack at the consumer/wellness end of the market.
• Neurosity: Neurosity produces consumer EEG devices (Notion, Crown) with a software platform for focus and cognitive augmentation. Comparable as an integrated EEG hardware + cognitive OS stack targeting developers and prosumers.

Broad incumbents

• Synchron: Synchron develops implantable BCI technology for medical applications including paralysis assistance. While more invasive and clinical in focus, it represents a broader neurotech incumbent pursuing brain-computer interface deployment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fastneura

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FastNeura